Skip to search boxSkip to navigationSkip to main content

Association of hypertension with T594M mutation in β subunit of epithelial sodium channels in black people resident in London

  • E. H. Baker(corresponding author)
    ,
  • ,
  • G. A. Sagnella
    ,
  • M. Rothwell
    ,
  • A. K. Onipinla
    ,
  • N. D. Markandu
*Corresponding author for this work
  • St. George's University of London
    ,
  • Collège de France
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Background. Liddle's syndrome is a rare inherited form of hypertension in which mutations of the epithelial sodium channel result in increased renal sodium reabsorption. Essential hypertension in black patients also shows clinical features of sodium retention so we screened black people for the T594M mutation, the most commonly identified sodium-channel mutation. Methods. In a case-control study, 206 hypertensive (mean age 48.0 [SD 11.8] years, men:women 80:126) and 142 normotensive [48.7 [7.4] years; 61:81) black people who lived in London, UK, were screened for T594M. Part of the last exon of the epithelial sodium-channel β subunit from genomic DNA was amplified by PCR. The T594M variant was detected by single-strand conformational polymorphism analysis of PCR products and confirmed by DNA sequencing. Findings. 17 (8.3%) of 206 hypertensive participants compared with three (2.1%) of 142 normotensive participants possessed the T594M (odds ratio [OR] = 4.17 [95% CI 1.12-18.25], p = 0.029). A high proportion of participants with the T594M variant were women (15 of 17 hypertensive participants and all three normotensive participants), whereas women comprised a lower proportion of the individuals screened (61.2% hypertensive, 57.7% normotensive). However, the association between the T594M variant and hypertension persisted after adjustment for sex and body-mass index (Mantel-Haenszel OR = 5.52 [1.40-30.61], p = 0.012). Plasma renin activity was significantly lower in 13 hypertensive participants with the T594M variant (median = 0.19 ng mL-1 h-1) than in 39 untreated hypertensive individuals without the variant (median = 0.45 ng mL-1 h-1, p = 0.009). Interpretation. Among black London people the T594M sodium-channel β subunit mutation occurs more frequently in people with hypertension than those without. The T594M variant may increase sodium-channel activity and could raise blood pressure in affected people by increasing renal tubular sodium reabsorption. These findings suggest that the T594M mutation could be the most common secondary cause of essential hypertension in black people identified to date.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1388-1392 (5 pages)

Journal (Volume, Issue Number)

Lancet (Volume 351, Issue 9113)

Publication milestones

  • Published - 05/09/1998

Publication status

Published - 05/09/1998

ISSN

0140-6736

Publication IDs

  • Scopus: 0032499488
  • PubMed: 9593408

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.08
Fractional count
12
Fractional count
0.92
Fractional count
1
Fractional count
1
SciVal
FWCI
29.01
SciVal
Author count
13
SciVal
citations
224
SciVal
Paper percentile
98
SciVal
Top percentile
5

PlumX, opens in new tab

Captures
57
Citation count
227

Funding Details

This study was supported by the British Heart Foundation. The Wandsworth Heart and Stroke Study was supported by the Wandsworth Health Authority, the South West Thames Region, the NHS Research and Development, the British Heart Foundation, and the British Diabetic Association. AP was partly supported by the Societe Francaise d' Hypertension Arterielle. We thank Andrew Crosby, Steve Jeffrey, Patrick Tarpey, and Chrissie Fenske of the Medical Genetics Unit for their scientific contributions. We also thank Alison Blackwood, Liz Folkerd, and Michelle Miller for the assays of plasma renin activity and plasma aldosterone.
FundersFunding numbers
British Diabetic Association
-
Wandsworth Health Authority
-
South West Thames Kidney Fund
-
BHF
-